For the three selected cell types, differential analysis between COVID-19 and control groups returned 3,061 sites for CD8 TEM, 1,301 sites for CD14 Mono, and 1,778 sites for NK (Supplementary Table 5; Methods section ‘COVID-19 PBMC scATACseq data analysis’). The gene discussed is CD8A; the disease is COVID-19.